Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Placebo-Controlled Evaluation of Effectiveness of Oral Naltrexone in Management of Adolescent Eating Disorders

NCT05073679 is registered in ClinicalTrials.gov with Rosemary Claire Roden as lead sponsor.

NCT NCT05073679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05073679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Placebo-Controlled Evaluation of Effectiveness of Oral Naltrexone in Management of Adolescent Eating Disorders
Lead sponsor
Rosemary Claire Roden
Phase
Phase 2/3
Overall status
Terminated
Start date
April 22, 2022
Completion date
May 21, 2024
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anorexia in adolescence, anorexia nervosa, atypical, anorexia nervosa, binge eating/purging type, anorexia nervosa/bulimia, bulimia nervosa, eating disorders, eating disorders in adolescence, impulsive behavior, purging (eating disorders)